Atlas Trials

Human Epidermal Growth Factor 2 Positive Carcinoma of Breast

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Human Epidermal Growth Factor 2 Positive Carcinoma of Breast

RecordFirmDate
Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib (NCT05323955)Carey Anders, M.D.2023-03-23

Track Human Epidermal Growth Factor 2 Positive Carcinoma of Breast automatically

Every clearance here is in the API, with alerts when new ones post.